Alzheimer's & Dementia Marks First Issue
New Alzheimer's Association Journal Is Available Now
Philadelphia, PA. October 11, 2005— Elsevier, world-leading scientific and medical publisher, and the Alzheimer’s Association are pleased to announce the recent publication of the premiere issue of Alzheimer's & Dementia: The Journal of the Alzheimer's Association. Zaven Khachaturian, Ph.D. — a renowned authority in brain aging, brain health, and Alzheimer's disease — serves as the Founding Editor-in-Chief.
Alzheimer's & Dementia focuses on "bench-to-bedside" studies, drawn from the many scientific and healthcare disciplines involved in this burgeoning area of research. In addition to peer-reviewed research, the journal presents reviews and expert perspectives from leaders in contributing disciplines, as well as editorials and special issues on topics of interest. Abstracts are available free online at the journal’s website, www.alzheimersanddementia.org. Individual subscribers may access the full text of all journal content online, and institutions may access the journal online through ScienceDirect, the leading online platform for libraries.
Highlights of the premiere issue include research linking a diet high in folate to a reduced risk of Alzheimer's disease. In that study, Alzheimer's disease risk was reduced by 55 percent for older adults with a total folate intake at or above the U.S. RDA of 400 micrograms per day. Other studies address potentially new approaches to early identification and treatment of Alzheimer's disease and dementia, including the possible protective effect of treatment for high blood pressure.
Alzheimer's & Dementia will be published quarterly, along with a special supplement containing abstracts of papers from each biannual International Conference on Alzheimer’s Disease and Related Disorders. Manuscripts are being accepted now through Elsevier's online submission and editorial system, accessible at http://ees.elsevier.com/adj/.
"It is a privilege to work with the Alzheimer's Association in producing this pioneering journal," comments Cynthia Baudendistel, Executive Publisher of Alzheimer's & Dementia for Elsevier. " Alzheimer's & Dementia will prove a uniquely valuable resource to all professionals in the field — from neurobiologists doing basic science research to physicians and others providing frontline care."
# # #
About the Alzheimer's Association
The Alzheimer's Association, the world leader in Alzheimer research and support, is dedicated to finding prevention methods, treatments and an eventual cure for Alzheimer’s. For nearly 25 years, the donor-supported, not-for-profit Alzheimer’s Association has provided reliable information and care consultation; created supportive services for families; increased funding for dementia research; and influenced public policy changes. The Alzheimer’s Association’s vision is a world without Alzheimer’s and its dual mission is to eliminate Alzheimer’s disease through the advancement of research and to enhance care and support for individuals, their families and caregivers. For more information, visit www.alz.org or call 1.800.272.3900.
Elsevier is a global information analytics company that helps institutions and professionals progress science, advance healthcare and improve performance for the benefit of humanity. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, more than 35,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX Group, a world-leading provider of information and analytics to professionals and business customers, in a wide range of industries. www.elsevier.com
Name Rachel Zaleski
Strategic Marketing Manager, Periodicals Marketing